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Infection with tissue-migrating helminths is frequently associated with intense granulocyte infiltrations.
Several host-derived factors are known to mediate granulocyte recruitment to the tissues, but less attention has
been paid to how parasite-derived products trigger this process. Parasite-derived chemotactic factors which
selectively recruit granulocytes have been described, but nothing is known about which cellular receptors
respond to these agents. The effect of products from the nematodes Ascaris suum, Toxocara canis, and Anisakis
simplex on human neutrophils were studied. We monitored four parameters of activation: chemotaxis, cell
polarization, intracellular Ca21 transients, and priming of superoxide anion production. Body fluids of A. suum
(ABF) and T. canis (TcBF) induced strong directional migration, shape change, and intracellular Ca21
transients. ABF also primed neutrophils for production of superoxide anions. Calcium mobilization in re-
sponse to A. suum-derived products was completely abrogated by pretreatment with pertussis toxin, implicating
a classical G protein-coupled receptor mechanism in the response to ABF. Moreover, pretreatment with
interleukin-8 (IL-8) completely abrogated the response to ABF, demonstrating desensitization of a common
pathway. However, ABF was unable to fully desensitize the response to IL-8, and binding to CXCR1 or CXCR2
was excluded in experiments using RBL-2H3 cells transfected with the two human IL-8 receptors. Our results
provide the first evidence for a direct interaction between a parasite-derived chemotactic factor and the host’s
chemotactic network, via a novel G protein-coupled receptor which interacts with the IL-8 receptor pathway.
Neutrophilic and eosinophilic granulocytes have evolved in
the immune system as a first line of defense against invading
pathogens. Remarkable numbers of eosinophils or neutrophils
infiltrate lesions caused by tissue-invading parasites, as seen,
e.g., in anisakiasis (57) and schistosomiasis. A series of chemo-
kines and low-molecular-weight attractants are known to me-
diate recruitment of granulocytes to the site of infection (56),
but less attention has been paid to the role of parasite-derived
products in inflammatory infiltration. Indeed the question of
whether host innate cells bear “danger” receptors for parasite
products has barely been explored. In parasitic infections,
there can be phenomenal intensity and selectivity of granulo-
cyte recruitment, such as the eosinophilic phlegmons (large
granulomatous infiltrations of eosinophils with marked sub-
mucosal oedema) caused by Anisakis simplex (anisakiasis or
eosinophilic gastroenteritis) (17, 28, 30, 31) and Ancylostoma
caninum (eosinophilic enteritis) (52, 70). Since most of the
damage caused by tissue-invading parasites can be attributed
to the recruited inflammatory cells, a clear picture of the mech-
anisms mediating granulocyte recruitment and activation is of
pivotal importance to the understanding and management of
pathology.
The intensity and selectivity of inflammatory recruitment
suggest that granulocytes are not simply responding to tissue
injury caused by migrating larvae, but are actively targeting or
being targeted by the parasites in question. Numerous para-
site-derived chemotactic factors (PDCFs) have been reported
to recruit, often selectively, neutrophils (neutrophil chemotac-
tic factors [NCFs]) or eosinophils (eosinophil chemotactic fac-
tors [ECFs]) (20, 26, 43, 46–48, 51, 67, 68). Few of those,
however, have been identified and cloned (20, 45). Moreover,
no study has yet addressed the nature of the host cell receptors
involved in this process despite the recognized importance of
innate system receptors. Here, we present the first evidence
that a neutrophil chemokine or related receptor may be in-
volved in this response. Previous studies addressing granulo-
cyte chemotaxis induced by PDCFs used granulocyte prepara-
tions with various degrees of purity from peritoneal exudate
cells of guinea pigs treated with oyster glycogen or horse serum
(26, 67, 68). From these studies, it is not clear to what extent
the cells used were immunologically primed or contaminating
cells played a role as a secondary source of chemotactic factors.
Chemoattractants have been divided into two categories by
Haines et al. (23). The main category is represented by the
classical chemoattractants such as formyl-Met-Leu-Phe (fMLP),
platelet-activating factor (PAF), leukotriene B4 (LTB4), and
C5a. The isolation of interleukin-8 (IL-8) (59) over a decade
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ago heralded a new group of chemoattractant molecules, the
chemoattractant cytokines (chemokines) (4, 5, 54, 58), and
their receptors (37, 42, 58, 72). Both classical chemoattractants
and chemokines act on target cells through seven-transmem-
brane-domain receptors that are coupled to heterotrimeric G
proteins (42). Their engagement by an agonist results in a
panoply of possible functional cellular responses, most of
which are rapid and transient, e.g., a characteristic rise in the
cytosolic Ca21 concentration ([Ca21]i) (4), polymerization and
depolymerization of actin filaments (15, 73), generation of
reactive oxygen species (16), and bioactive lipids (e.g., PAF
and LTB4) (6, 55), priming of superoxide anion production
(e.g., by PAF and tumor necrosis factor alpha [TNF-a]) (19,
29), and transendothelial migration (64). The second category
is represented by the so-called pure chemoattractants and in-
cludes substance P (23), fibrinopeptide B (62), transforming
growth factor b1 (TGFb1) (23, 53), and Fas ligand (FasL) (44,
61). These chemoattractants are active at extremely low con-
centrations (TGFb1 at femtomolar and FasL at pico- to nano-
molar concentrations) (44, 61) and do not elicit a transient
[Ca21]i increase or any degranulation (44, 53) or superoxide
anion production at any concentration (23, 62). With respect to
their receptors, pure chemoattractants bind to G protein-cou-
pled receptors (substance P) (23) as well as to different recep-
tors such as Fas (CD95 and Apo-1), the receptor for FasL (44).
In this study, we demonstrate for the first time that the previ-
ously described NCF from Ascaris suum (68) exerts classical-
like activities on human neutrophils, since its effects on target
cells include pertussis toxin (PTX)-sensitive Ca21 mobiliza-
tion, shape change, priming of superoxide anion production,
and in vitro chemotaxis.
MATERIALS AND METHODS
Parasites and extracts. Parasite body fluids were obtained from the adult
stages of A. suum (Ascaris body fluid [ABF]) and Toxocara canis (T. canis body
fluid [TcBF]) from naturally infected pigs and dogs, respectively. Body fluid was
collected by an incision in the cuticle. The body fluids were then microcentri-
fuged at 16,000 3 g at 4°C for 15 min, and the supernatants were stored at
270°C. Third-stage larvae of Anisakis simplex were obtained by dissection of
fresh, unfrozen mackerel (Scomber scombrus) or herring (Clupea harengus) from
the North Sea. Somatic extracts of A. simplex (AnX) were obtained by snap-
freezing the larvae in liquid nitrogen and grinding them to a fine powder in a
mortar; 10 g of powder was extracted with 20 ml of phosphate-buffered saline
(PBS, pH 7.2) at room temperature for 30 min. The extracts were then micro-
centrifuged at 16,000 3 g at 4°C for 30 min, and the supernatants were stored at
270°C. All protein concentrations were determined with the Coomassie Plus
protein assay reagent (Pierce, Rockford, Ill.) as directed.
Purification of granulocytes. Neutrophils or eosinophils were purified from
freshly drawn peripheral blood of healthy donors (71). Briefly, granulocytes were
obtained via a two-stage protocol consisting of dextran sedimentation and a
three-step isotonic discontinuous Percoll gradient (55, 70, and 81%) centrifuga-
tion. The cells derived from the 55 to 70% interface were 95 to 99% neutrophils.
Eosinophils were purified from the neutrophil-rich interface by a negative im-
munomagnetic selection step using sheep anti-mouse immunoglobulin G Dyna-
beads, coated with murine anti-CD16 (3G8; kind gift of J. Unkeless, Mount Sinai
Medical School, New York, N.Y.). Final purities were 95 to 99% for neutrophils
and .99% for eosinophils, as assessed by cytospins stained with Diff-Quik (Dade
Diagnostika, Unterschleissheim, Germany) according to the manufacturer’s in-
structions. Viability (trypan blue dye exclusion) was at least 99% for both cell
types. All buffers used during purification were Ca21- and Mg21-free.
Chemotaxis experiments. Chemotaxis assays were performed in a 96-well
modified Boyden chamber (Neuro Probe, Gaithersburg, Md.). Positive and neg-
ative controls in the bottom wells as well as the granulocyte suspension in the
upper wells were in Hanks’ balanced salt solution (HBSS) (Gibco, Paisley,
United Kingdom) with 0.3% bovine serum albumin (BSA) (Sigma, Poole, United
Kingdom). The polyvinylpyrrolidone-free polycarbonate membranes (Neuro
Probe) had a 3-mm pore diameter. As pointed out by Wilkinson (74), a source of
error with this technique is the potential aggregation of cells during migration,
resulting in adhesion to the lower surface of the filter rather than to the bottom
wells. Therefore, both the cells adhering to the lower surface of the filter and the
cells migrating to the bottom wells were measured as described below. Neutro-
phil suspension (200 ml, 107/ml) was added to the top wells, and the chemotaxis
chamber was incubated at 37°C in humidified air with 5% CO2 for 45 min. The
chemotaxis chamber was then carefully disassembled, and the upper side of the
filter was washed with PBS, scraped with a cell scraper to remove adherent cells,
fixed with methanol, and stained with Diff-Quik. The stained filters were mea-
sured in a 96-well spectrophotometer at 550 nm. The cells that had migrated into
the bottom wells were counted in five high-power fields with a light microscope
in a modified Neubauer hematocytometer. All treatments in each chemotaxis
experiment were performed in triplicate. Chemotaxis was expressed as the che-
motactic index (C.I.), defined as the number of cells migrating in the presence of
the sample divided by the number of cells migrating in the presence of medium
only.
Measurement of cytosolic Ca21 concentration. Ca21 mobilization was mea-
sured with Fura-2 according to the following protocol. Purified neutrophils or
eosinophils were resuspended at a density of 107/ml in Ca21-Mg21-free HBSS–
0.3% BSA without phenol red and incubated in a waterbath at 37°C (for all
RBL-2H3 experiments at room temperature) in the presence of 2 mM Fura-2
AM (Molecular Probes, Eugene, Oreg.), followed by two washes in the above
medium. Stable transfectant RBL-2H3 cell lines expressing the human CXCR1
or CXCR2 receptor (generously provided by Ingrid Schraufstätter, La Jolla
Institute for Experimental Medicine) were grown in RPMI 1640 supplemented
with 10% heat-inactivated fetal calf serum (Sigma), penicillin (100 U/ml), strep-
tomycin, (100 mg/ml), gentamicin (50 mg/m), and G418 (0.5 mg/ml) (Promega,
Madison, Wis.). The Fura-2-loaded cells were then resuspended at a density of
2 3 106/ml in optical methacrylate (PMMA) disposable cuvettes (Kartell; Merck,
Poole, United Kingdom) in 2.5 ml of HBSS–0.3% BSA with Ca21 and Mg21.
Ca21 mobilization into the cytosol was monitored at 340 and 380 nm (excitation)
and 510 nm (emission) with a spectrofluorimeter (FluoroMax; Spex Industries,
Edison, N.J.) using the dM3000 Software (Spex Industries). Ca21 concentrations
were calculated using the Grynkiewicz equation (22). For PTX inhibition exper-
iments, purified cells were incubated for 90 min at 37°C at a density of 107/ml in
HBSS–0.3% BSA in the presence of PTX (2 mg/ml) (Alexis Corp., San Diego,
Calif.) before loading with Fura-2.
Measurement of neutrophil polarization. Shape change was assessed using a
modification of the method described by Kitchen et al. (34): 90 ml of a 106/ml
suspension of neutrophils in HBSS–0.3% BSA was incubated at 37°C in a shak-
ing waterbath for 15 min in the presence of 10 ml of buffer or sample. The cells
were then fixed by adding 100 ml of 2.5% glutaraldehyde in saline. Samples were
analyzed for shape change by flow cytometry (EPICS Profile II; Coulter Elec-
tronics, Luton, United Kingdom). Percent shape change was determined by
analyzing the whole cell population and gating on the mean forward light scatter
of the non-shape-changed cells.
Superoxide anion production and priming experiments. Superoxide anion
production of neutrophils was assessed with dihydrorhodamine 123 (DHR123)
as described by Stocks et al. (65). Cells were incubated at a density of 106/ml in
HBSS–0.3% BSA with 1 mM DHR123 (Molecular Probes) for 5 min at 37°C
before adding a stimulus or buffer. The cells were then incubated for 12 min at
37°C in a shaking waterbath and immediately placed on ice. For the priming
experiments, cells were incubated for 10 min at 37°C prior to incubation with
DHR123. Superoxide anion production was analyzed by flow cytometry (EPICS
Profile II) by detecting fluorescence in the green channel due to the conversion
of DHR123. Data were expressed as mean fluorescence intensity of the totality
of cells in the sample. For the priming experiments, any potential lipopolysac-
charide (LPS) contaminants in ABF were removed with polymyxin B-Sepharose
(Detoxi-Gel AffinityPak Prepacked columns; Pierce and Warriner, Cheshire,
United Kingdom) according to the manufacturer’s instructions.
S-300HR gel filtration. ABF (1 ml) was spun at 16,000 3 g in a microcentrifuge
for 10 min and applied at 5 mg/ml with 5% glycerol to the column (flow rate, 0.33
ml/min). Following the elution of the void volume, 40 to 45 fractions (2 ml/
fraction) were collected. Protein eluting from the column was monitored by
absorbance at 280 nm.
Statistics. All data are expressed as mean 6 standard deviation (SD) of n
separate experiments, performed in duplicate or triplicate. The paired t test was
used for comparison of different treatments, and P , 0.05 was considered
significant.
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RESULTS
A. suum and T. canis but not A. simplex induce a strong
chemotactic response in human neutrophils. The induction of
chemotaxis in unprimed, high-purity populations of neutro-
phils obtained from peripheral blood of healthy human donors
was tested using a 96-well chemotaxis chamber, and the extent
of migration was assessed by counting the cells that migrated to
the bottom wells. ABF and TcBF both induced a strong dose-
dependent chemotactic response within the protein concentra-
tion range from 500 mg/ml to 500 ng/ml (Fig. 1). Checkerboard
titration experiments with ABF confirmed that the enhanced
neutrophil migration was chemotactic rather than chemoki-
netic (data not shown). Somatic extracts of A. simplex (AnX),
however, did not elicit a measurable chemotactic response in
the same protein concentration range.
ABF and TcBF induce transient intracellular Ca21 ion ele-
vations in neutrophils. Since classic chemotactic factors such
as C5a and chemokines induce [Ca21]i transients upon engage-
ment of their receptors (3, 22), we asked whether ABF and
TcBF, in addition to their chemotactic effect on neutrophils,
also mobilize Ca21 ions in Fura-2-loaded cells. As shown in
Fig. 2, both ABF and TcBF induced a rapid, strong, and tran-
sient elevation of [Ca21]i in neutrophils when used at 50 mg/ml.
The intensity of the Ca21 mobilization was dose dependent
and still detectable with ABF diluted 1:104 (total protein con-
centration of 5 mg/ml; data not shown). ABF also mobilized
Ca21 in purified peripheral blood eosinophils, although more
weakly (data not shown), and in the human monocytic cell line
THP-1, which is known to bear one or more IL-8 receptors
(data not shown). Consistent with its lack of chemotactic ac-
tivity on neutrophils, AnX did not increase [Ca21]i up to a
protein concentration of 250 mg/ml.
ABF and TcBF induce rapid and reversible shape change in
neutrophils. A very dramatic effect elicited in target cells upon
binding of chemotactic factors to their receptors is the phe-
nomenon of cell polarization. Within a few minutes, a cell that
has encountered an appropriate chemotactic stimulus changes
from a spherical to a highly polarized morphology (24). The
shape change can be visualized under a light microscope (10)
or more conveniently assessed by recording the increase in the
forward angle light scatter in a flow cytometer (10, 63). Figures
3A to D show representative flow cytometry histograms of
untreated neutrophils (A and B) or neutrophils treated with
100 nM fMLP (C) or ABF at 50 mg/ml (D) for 15 min, dem-
onstrating the strong shape change of neutrophils incubated
with parasite products. Figure 3E shows the effect of serial
dilutions of ABF, TcBF, and AnX on the shape of neutrophils,
expressed as the percentage of cells affected. A nonchemotac-
tic protein (chicken ovalbumin) was included to control for
nonspecific effects of high protein concentrations. Neither
FIG. 1. In vitro chemotaxis of human neutrophils induced by prod-
ucts of ascarid nematodes. TcBF and ABF but not AnX, induced
strong and dose-dependent granulocyte migration. Isolated neutro-
phils (107/ml) were added to the top wells of a multiwell chemotaxis
chamber, and serial dilutions were added of the samples to the bottom
wells. Protein concentrations were 500 mg/ml (1:10) to 500 ng/ml (1:
104) for TcBF and ABF and 1,000 mg/ml (1:10) to 1,000 ng/ml (1:104)
for AnX. fMLP was used at 10 nM, as higher concentrations led to
strong aggregation of the neutrophils in the filter concurrent with a loss
of migration to the bottom wells. Values represent the mean 6 SD of
three separate experiments with different donors performed in tripli-
cate. SD values falling within the symbols are not shown.
FIG. 2. Mobilization of [Ca21]i in human neutrophils by products
of ascarid nematodes. TcBF and ABF (50 mg/ml) but not AnX (250
mg/ml) induced rapid and strong Ca21 transients in the cytosol of
purified neutrophils. Each experiment was repeated with at least three
different donors with comparable results.
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ovalbumin (from 5 mg/ml to 50 ng/ml) nor AnX had a signif-
icant effect on the shape of neutrophils, whereas ABF and
TcBF caused strong and dose-dependent shape change com-
parable to the intensity caused by 100 nM fMLP. ABF-induced
shape change could be detected with dilutions of up to 1:106
(corresponding to approximately 50 ng of total protein per ml)
but was only detectable at higher concentrations with TcBF
(500 and 50 mg/ml). Shape change induced by ABF was rapid,
beginning within seconds and peaking within 5 to 15 min,
depending on the donor, and reverting to basal level within 30
to 60 min (data not shown). This profile is very similar to the
time course of shape change elicited by PAF (34) and IL-8
(F. H. Falcone and A. G. Rossi, unpublished data) and clearly
different from the time course of shape change caused by, e.g.,
TNF-a or LPS (34).
ABF effectively primes neutrophils for fMLP-induced super-
oxide production. Several factors, such as IL-8, are known to
induce an oxidative burst in neutrophils, evident in the pro-
duction of superoxide anion (32). The induction of the oxida-
tive burst, however, depends on the state of preactivation
(priming) of the neutrophils by inflammatory factors such as
PAF, TNF-a, and LPS (49). While these factors do not them-
selves stimulate an oxidative burst, they considerably increase
this response upon a second stimulation, e.g., with fMLP (19,
29). We therefore asked whether ABF, in addition to causing
Ca21 mobilization, shape change, and directional movement of
neutrophils, can also prime neutrophils for enhanced superox-
ide anion production. Figure 4 shows the results of the oxida-
tive burst analysis with DHR123. Treatment of neutrophils
with 10 nM PAF or ABF (50 mg/ml) led to only a slight
increase in superoxide anion production which was not signif-
icantly higher than in the unstimulated control. fMLP at 10 nM
led to a 2.9-fold increase. Priming with 10 nM PAF 15 min
prior to exposure to 10 nM fMLP led to a ninefold increase
over the spontaneous oxidative activity. A similar increase
(10.2-fold) was obtained when neutrophils were preincubated
with ABF (50 mg/ml), showing that ABF, without inducing an
oxidative burst itself, can efficiently prime neutrophils for su-
peroxide anion production. ABF retained its priming efficiency
after treatment with a polymyxin B-Sepharose column, exclud-
ing putative contamination with LPS as a possible source of
priming (data not shown). Maximal (92-fold) increase was ob-
tained with 100 nM phorbol myristate acetate (PMA) (not
shown).
FIG. 3. Flow cytometry histograms illustrating the shape change of
unprimed isolated neutrophils induced by different samples. Neutro-
phils were incubated with the stimuli at 37°C and fixed with 2.5%
glutaraldehyde after 15 min. The autofluorescence or forward scatter
of the cells was monitored on a Coulter EPICS II flow cytometer; plots
show forward scatter (FS) against log side scatter (LSS). (A and B)
Unprimed, unstimulated neutrophils; (C) ABF (500 mg/ml); (D) 100
nM fMLP. (E) ABF and TcBF but not AnX induce strong and revers-
ible shape change in neutrophils. Dose-response curves obtained with
the parasite products and controls. Shown are the results of three
independent experiments performed in duplicate with different do-
nors, expressed as mean percentage of cells that have undergone shape
change 6 SD. Also shown are 100 nM fMLP and the background
shape change of unstimulated neutrophils. Protein concentrations
were: ABF, TcBF, and AnX, 500 mg/ml (1:10) to 50 ng/ml (1:105);
ovalbumin (OVA), 5 mg/ml (1:10) to 500 ng/ml (1:105). FIG. 4. ABF primes purified neutrophils for superoxide anion pro-
duction. Cells were incubated at 37°C with the putative priming factors
or buffer (med) for 10 min, loaded for 5 min with DHR123, and
incubated for 12 min with the following stimuli: 100 nM PAF, 100 nM
fMLP, ABF (500 mg/ml), or 100 nM PMA. Superoxide anion produc-
tion was then measured. Values represent the mean total fluores-
cence 6 SD for five independent duplicate determinations with dif-
ferent donors. p, P , 0.05; pp, P , 0.001.
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FIG. 5. Cross-desensitization experiments with ABF (50 mg/ml) and the main chemotactic factors for neutrophils. Ca21 influx was monitored
with Fura-2-loaded neutrophils. (A) Desensitization of the response to ABF by 100 nM fMLP. (B) There was no cross-desensitization between 10
nM C5a and ABF (C and D), and 100 nM PAF also failed to desensitize the response to ABF as well as to 100 nM fMLP (E and F). (G)
Desensitization of ABF-induced Ca21 influx by IL-8. (H) Partial desensitization of the response to IL-8 by ABF. (I) Pretreatment with 100 nM
NAP-2. (J) Partial (;30%) desensitization of the response to 100 nM NAP-2 by ABF. Comparable results were obtained in at least three separate
experiments with different donors.
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fMLP and IL-8 desensitize the Ca21 mobilization induced
by ABF. Our next set of experiments were designed to charac-
terize the putative receptor mediating the effects of ABF on
neutrophils. These experiments exploit the phenomenon of
receptor cross-desensitization. Homologous desensitization is
caused by a decreased affinity of the receptor-ligand complex
for G proteins and its subsequent internalization in an arrestin-
dependent process, resulting in a lower response upon restimu-
lation with the same stimulus (3). Heterologous desensitization
is not dependent on receptor internalization and occurs when
a receptor loses responsiveness as a consequence of a ligand’s
binding to a different receptor (3). Figure 5 illustrates different
combinations of chemoattractant stimuli relevant to neutro-
phils with ABF. When neutrophils are first stimulated with 100
nM fMLP, the increase in [Ca21]i in response to ABF is com-
pletely abrogated (Fig. 5A), whereas 10 nM C5a (Fig. 5C and
D) and 100 nM PAF (Fig. 5E and F) do not affect the response
significantly. Interestingly, 100 nM recombinant IL-8 almost
totally desensitized the response to ABF (50 mg/ml) (Fig. 5G).
ABF (50 mg/ml) partially desensitized the responses to 100 nM
IL-8 (Fig. 5H) and 100 nM PAF (Fig. 5F) but not to 10 nM C5a
(Fig. 5D) or 100 nM fMLP (Fig. 5B), and 100 nM neutrophil
activation protein 2 (NAP-2), which is known to bind with high
affinity to the chemokine receptor CXCR2 and to CXCR1 with
200-fold-lower affinity (36), did not desensitize the response to
ABF (50 mg/ml) (Fig. 5I). Interestingly, pretreatment with
ABF (50 mg/ml) led to a partial (about 30%) but consistent
desensitization of the response to 100 nM NAP-2 (Fig. 5J).
When used in lower concentrations, fMLP (#5 nM) failed to
desensitize the response to ABF (Fig. 6B). We also found that
ABF and TcBF cross-desensitized each other’s induction of
Ca21 mobilization in neutrophils (data not shown). Taken to-
gether, the desensitization studies point to interactions be-
tween the receptors for fMLP (fMLP-R) and IL-8 (CXCR1
and CXCR2) in the Ca21 mobilization response to ABF. To
further explore this possibility and to assess the potential role
of other receptors, we performed a second set of experiments
using specific receptor antagonists.
Specific antagonists of fMLP-R, PAF-R, and LTB4-R do not
inhibit ABF-induced Ca21 mobilization. Figure 6 shows the
results of incubation of neutrophils with specific antagonists.
Neutrophils incubated with 5 mM N-t-BOC-MLP for 5 min
prior to stimulation lost responsiveness to 10 nM fMLP but still
responded fully to ABF (Fig. 6A and B). A 3-min incubation
with 5 mM CP-105,696 (kind gift from Henry Showell, Pfizer,
Groton, Conn.), a specific antagonist of the LTB4-R (36),
blocked the response to 10 nM LTB4 but not to ABF or fMLP
(Fig. 6C). A 5-min incubation with the PAF-R antagonist UK-
74,505 (2) (kind gift of J. Parry, Pfizer, Sandwich, U.K.) at 1
mM, shown in Fig. 6E, also failed to inhibit the response to
ABF. These results exclude a role of the receptors for fMLP,
PAF and LTB4 in ABF-induced Ca
21 mobilization. Taken to-
gether, the desensitization and receptor antagonist studies sug-
gest that the effect of ABF on neutrophils may be mediated via
one of the receptors for IL-8, i.e., CXCR1 or CXCR2.
FIG. 6. Receptor-antagonist experiments with ABF (50 mg/ml) and specific antagonists of the receptors for fMLP (5 mM Nt-BOC-MLP, 5 min
of incubation), LTB4 (5 mM CP-105,696, 3 min of incubation), and PAF (1 mM UK-74,505, 5 min of incubation). These experiments were repeated
at least three times with different donors and comparable results.
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[Ca21]i transients in CXCR1 and CXCR2 transfectants are
not desensitized by IL-8 or NAP-2. To further investigate the
putative role of the IL-8 receptors in Ascaris-dependent che-
motaxis, we monitored the mobilization of intracytosolic Ca21
fluxes in RBL-2H3 cells transfected with either CXCR1 or
CXCR2. As shown in Fig. 7, RBL cells transfected with
CXCR1 responded to IL-8 (10 nM, Fig. 7A), whereas RBL-
2H3 cells transfected with CXCR2 responded to NAP-2 (100
nM, Fig. 7C). Nontransfected RBL-2H3 cells did not respond
to either chemokine. Unexpectedly, nontransfected RBL-2H3
cells showed a weak but consistent response to ABF, implicat-
ing a novel, endogenous receptor present on the rat cells (Fig.
7E and F). Significantly, there was no cross-desensitization
between ABF and IL-8 (Fig. 7A and B) on CXCR1 transfec-
tants or between ABF and NAP-2 (Fig. 7C and D) on CXCR2
transfectants, excluding these receptors from being the target
of the NCF in ABF on human neutrophils. In addition, it was
found that extended trypsin treatment of the transfectant cell
lines (45 min at 37°C) completely ablated the response to ABF
but did not reduce the response to IL-8 or NAP-2 (data not
shown), lending further support to the proposition that a dis-
tinct receptor may mediate Ascaris-dependent chemotaxis in
human neutrophils.
Inhibition of Ca21 mobilization in neutrophils by PTX
treatment. Since classical chemotactic receptors are coupled to
heterotrimeric, pertussis toxin-sensitive G proteins, we inves-
tigated the effect of treatment with PTX (2 mg/ml) on ABF-
induced mobilization of Ca21. Figure 8 shows purified neutro-
phils stimulated with 10 nM fMLP without (Fig. 8A) or after
PTX treatment (Fig. 8B), which leads to a total inhibition of
Ca21 mobilization. ABF-induced Ca21 mobilization (Fig. 8C)
was also totally abrogated by PTX (Fig. 8D). Pretreatment
with PTX, however, did not affect the influx of Ca21 induced
by 10 nM ionomycin, showing that the cells are still fully re-
sponsive (Fig. 8E and 8F).
Fractionation of Ascaris body fluid. Previous work per-
formed with ABF led to the identification and biochemical
characterization of separate molecular entities attracting neu-
trophils and eosinophils (68). Both NCF and ECF had an
approximate size of 30 kDa. The neutrophil chemotactic frac-
tion could be further separated into two distinct NCFs by
isoelectric focusing (pIs of 5.2 and 7.6), which are possibly
isoforms. We have performed a preliminary separation of ABF
by size exclusion chromatography and tested whether, upon
separation, Ca21 mobilization, shape change, and chemotactic
activity were coincident with a particular fraction. Activity in
all three parameters was found exclusively in 5 of 45 fractions
corresponding to an apparent mass ranging between 12.5 and
66 kDa (Fig. 9). These results precisely match the distribution
of chemotactic activity described by Tanaka et al. (68). Since
up to 50% of the protein of ABF is known to be made up by
ABA-1, a retinoid and fatty acid-binding protein with a mass of
14.4 kDa (33), we asked whether ABA-1 could induce compa-
rable immunologic effects in purified human neutrophils.
FIG. 7. Ca21 mobilization by ABF in RBL-2H3 cell lines stably transfected with human CXCR1 (A and B) or CXCR2 (C and D). ABF induces
a weak Ca21 mobilization (via an endogenous receptor) in nontransfected as well as in transfected cell-lines (A to F), which is not desensitized
by IL-8 (10 nM, A and B) or NAP-2 (100 nM, C and D). The nontransfected RBL cell line does not respond to the human chemokines (E and
F). These experiments were repeated at least four times with comparable results.
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ABA-1 is also known to occur as a dimer with an approximate
mass of 30 kDa and has a predicted isoelectric point of 7.55.
Both physicochemical characteristics of ABA-1 are very close
to the properties of one of the two NCFs described by Tanaka
et al. (68). Since a homologue of ABA-1 in Dirofilaria immitis
is chemotactic for neutrophils (11, 45) and the primary amino
acid sequence of a variant of ABA-1 contains an ELR motif
(41), which is well known to play an important role in neutro-
phil chemotaxis (25), ABA-1 is the top candidate as a putative
NCF. We therefore tested parasite-derived purified (by size
exclusion chromatography with fast protein liquid chromatog-
raphy) and recombinant (obtained as described [39]) ABA-1
(both kindly provided by M. W. Kennedy, Glasgow, U.K.) in
the Ca21 mobilization and chemotaxis assays. Neither form of
ABA-1 elicited Ca21 mobilization (tested at 20 mg/ml; data not
shown) in purified neutrophils or showed significant dose-de-
pendent chemotactic activity in our in vitro assay (range, 500
mg/ml to 500 ng/ml), except for a comparably small increase in
neutrophil migration with the highest concentration of the
parasite-derived ABA-1 (C.I 5 2; data not shown). The fact
that only 500 mg of purified but not recombinant ABA-1 per ml
induced neutrophil chemotaxis without eliciting measurable
Ca21 mobilization seems to indicate that the increased migra-
tion of neutrophils was caused by contaminants of similar size
(which were known to be present) in the preparation rather
than by ABA-1 itself.
DISCUSSION
We have shown that unprimed, purified human neutrophils
respond rapidly to nematode body fluid constituents by in vitro
chemotaxis, shape change, and Ca21 mobilization. Further-
more, the most active extract, ABF, very effectively primed
neutrophils for superoxide anion production.
The results of the cross-desensitization and receptor antag-
onist experiments indicated a possible involvement of either
CXCR1 or CXCR2 in ABF-dependent neutrophil recruit-
ment. The observed cross-desensitization by high concentra-
tions of fMLP was not caused by homologous desensitization,
since the receptor antagonist studies excluded this receptor
from being the target of the NCF in ABF. Rather, fMLP is
known to act as a strong (heterologous) desensitizer of Ca21
mobilization induced by IL-8 (3). The desensitization of ABF-
induced Ca21 mobilization by 100 nM fMLP also rules out the
involvement of the receptor FPRL1 as the putative receptor
for the NCF in our study. FPRL1 has recently been shown to
be a receptor for the acute-phase protein serum amyloid A
(SAA) (66). Due to the apparently low affinity of FPLR1 for
fMLP, only very high concentrations of fMLP (10 mM to 1
mM) are able to desensitize the response to SAA (66). Since
our study demonstrated a total desensitization of neutrophils
to ABF with 10 or 100 nM fMLP, we think that this result rules
out a possible involvement of FPLR1.
FIG. 8. Effect of pretreatment with PTX (2 mg/ml) on ABF-induced mobilization of Ca21. Neutrophils were stimulated with 10 nM fMLP
without (A) or with PTX pretreatment (B). ABF-induced Ca21 mobilization (C) was totally abrogated by PTX (D). Pretreatment with PTX did
not affect the Ca21 influx induced by 100 nM ionomycin (E and F). The data are representative of three experiments with the same results.
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Several results led us to assume an involvement of CXCR1
or CXCR2. PAF, when used as the first signal, did not desen-
sitize the Ca21 mobilization induced by ABF, but when ABF
was given first, the response to PAF was partially desensitized.
Such a partial (10 to 24%) desensitization of PAF signalling by
IL-8 has been described before (3). The effective induction of
Ca21 mobilization by ABF in THP-1 cells is also consistent
with a role of CXCR1 or CXCR2, since a receptor for IL-8 has
been described in these cells (21, 27). The Ca21 mobilization in
eosinophils is better explained by the activity of the ECF rather
than the NCF in ABF, since Petering et al. have recently shown
that eosinophils do not express receptors for IL-8 (50). The
observation that ABF did not significantly increase superoxide
anion production would point to CXCR2 rather than CXCR1
as the putative target receptor, since superoxide anion produc-
tion induced directly by IL-8 is mediated by CXCR1 but not
CXCR2 (32). In this context, the strong effect of ABF is con-
sistent with the known effective priming of neutrophils pre-
treated with IL-8 (14). Nevertheless, although all our initial
results indicated a possible involvement of CXCR2 (or
CXCR1), the experiments with the transfected cell lines led us
to reject this hypothesis. The strong cross-desensitization be-
tween IL-8 and ABF and the weaker (but consistent) desensi-
tization of the neutrophil response to NAP-2, however, suggest
that A. suum may directly affect neutrophils via a receptor that
interacts with both IL-8 receptors but not with the receptors
for fMLP, FPRL1, LTB4, or C5a and only weakly with the
receptor for PAF. Thus, our results raise the interesting pos-
sibility that human neutrophils may express a receptor which
may enable the immune system to detect, target, and ultimately
destroy tissue-migrating helminth larvae. Along these lines, the
observed priming for superoxide production by parasitic prod-
ucts such as those contained in ABF may serve to enhance the
immune response to the intruding parasite or alternatively
support scavenger-like functions such as the removal of dam-
aged or dead parasites. Future work will aim to test whether
secreted products can activate neutrophils by the same mech-
anism, or if the reaction is dependent upon body fluid compo-
nents released only by dead or dying organisms.
What is the biological significance of neutrophil attraction
FIG. 9. Distribution of stimulatory activities in size exclusion chromatography fractions of ABF. Shown are the chromatogram with the
calibration standards (A), the percent shape change (as described above), and chemotactic (obtained from the fixed and stained cells that migrated
through and adhered to the bottom side of the filter) activities in the single fractions (B), and the Ca21 mobilization (C) from Fura-2-loaded cells.
All three activities coincided in fractions 15 to 20. OD, optical density.
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by parasitic products? It is widely accepted that neutrophils are
of paramount importance as a first line of defense against bac-
teria. This is demonstrated by the hereditary disease chronic
granulomatous disease (60), in which a defect in the leukocyte
oxidase results in a severe deficiency in immunity to several,
especially catalase-positive, pathogens (40). Neutrophils are
highly responsive to fMLP and related formylated peptides.
N-Formylpeptides are bacterial products, and it can therefore
be assumed that the main receptor for these products, fMLP-R
(7, 8) (or FPR for formylpeptide receptor), plays an important
role in antibacterial defense. This view is strongly supported by
a recent study by Gao et al. (18), showing that FPR2/2 mice
display a significantly higher mortality than their wild-type
counterparts when challenged with Listeria monocytogenes. It is
therefore likely that an analogous recognition mechanism has
evolved to mediate responses to multicellular parasites, i.e.,
helminths. The association between helminth infection and
eosinophils has been known for over a century (9), but the role
of neutrophils has been less well appreciated. Indeed, the re-
cruitment of eosinophils may itself be indirect and mediated by
neutrophils. Neutrophils have the ability to release ECFs upon
diverse stimuli, including parasite-derived factors (12, 13, 35,
48), and have been proposed to be mediators of eosinophil
recruitment, e.g., in infection with Schistosoma japonicum (46).
A note of caution has to be made regarding the interpreta-
tion of our priming experiments. Bacterial endotoxin (LPS) is
the classical priming agent for neutrophils (1, 49), and we
cannot completely exclude the presence of minute amounts of
LPS or other bacterial contaminants in ABF, causing some
fraction of its priming effect. Treatment of ABF with poly-
myxin B-Sepharose did not affect its efficiency as a priming
agent. Furthermore, priming of neutrophils by LPS is strongly
dependent on the presence of mediators found exclusively in
serum or plasma (49) (e.g., LPS-binding protein [69] and sep-
tin [75]), which were absent in our assays. We therefore think
that putative bacterial contaminants cannot be responsible for
the strong priming of neutrophils by ABF.
In summary, we show for the first time how a PDCF con-
tained in ABF induces not only chemotaxis but also strong
activation of human neutrophils (calcium mobilization, shape
change, and priming of superoxide production) in vitro. To the
best of our knowledge, this is also the first report of an NCF
activity in T. canis. Our data indicate that these effects are
mediated by a receptor which interacts strongly with CXCR1
and weakly with CXCR2 and PAF-R, but is distinct from these
receptors and from the receptors for LTB4, C5a, fMLP (FPR),
and SAA (FPRL1). The strong and specific interaction with
the IL-8 receptor pathway and the PTX sensitivity suggest that
the target receptor is a member of the serpentine, heterotri-
meric G protein-coupled receptor superfamily. Future work
will address the molecular identity of this receptor on human
neutrophils.
We expect that the techniques used in this study, in combi-
nation with the advances in parasite genome sequencing and
the rapidly increasing knowledge about the chemokine net-
work, will enable a more thorough understanding of granulo-
cyte recruitment in helminth infections. The understanding of
the underlying mechanisms, in addition to suggesting new ther-
apeutic approaches for the treatment of acute parasite-induced
pathology, may also impact directly on our understanding of
the mechanism of allergic or inflammatory diseases.
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